International Journal of Prevention and Treatment
p-ISSN: 2167-728X e-ISSN: 2167-7298
2012; 1(4): 53-60
doi: 10.5923/j.ijpt.20120104.01
Tilahun Nigatu1, Geoffrey Setswe2, Julian Elliott3, Brian Oldenburg1
1Department of Epidemiology and Preventive Medicine, Monash University, Australia
2School of Health Sciences, Monash University, South Africa
3Infectious Disease Unit, Alfred Hospital, Australia
Correspondence to: Tilahun Nigatu, Department of Epidemiology and Preventive Medicine, Monash University, Australia.
Email: | ![]() |
Copyright © 2012 Scientific & Academic Publishing. All Rights Reserved.
The Political Declaration of High-level Meeting of the General Assembly on the Prevention and Control of NCDs has noted possible linkages between HIV/AIDS and NCDs. The aim of this study was to develop a public health framework for those linkages between HIV/AIDS and the common NCDs. The overall method used in this study was a thematic research synthesis. Descriptive, integrative and configurative syntheses of evidence on linkages between HIV/AIDS and NCDs were conducted. The searching process was iterative; appraisal was stepwise; and extraction was verbatim. All retrieved information was described, analysed and then configured in to a concept map using major pathways of relationships between HIV/AIDS and NCDs. The concept map was developed in to the public health framework through progressive review and revisions. Two major forms and pathways of linkages between HIV/AIDS and NCDs were identified. There are five nodes that mediate the indirect HIV-NCD linkage: common underlying factors, life style factors, antiretroviral treatment, common complications, and other mediating disease conditions. These linkages along with mediating factors are organized in to a public health framework. In conclusion, the main pathways and forms of relationship between HIV/AIDS and NCDs were described; and a public health framework for the epidemiological interrelationships between HIV/AIDS and NCDs was developed.
Keywords: Key words Epidemiological Linkage, Public Health Framework, HIV/AIDS , NCDs
Cite this paper: Tilahun Nigatu, Geoffrey Setswe, Julian Elliot, Brian Oldenburg, "Developing a Public Health Framework for the Epidemiological Linkages between HIV/AIDS and NCDs: A Thematic Research Synthesis", International Journal of Prevention and Treatment, Vol. 1 No. 4, 2012, pp. 53-60. doi: 10.5923/j.ijpt.20120104.01.
![]() | Figure 1. Flow chart of the searching, appraisal and extraction process |
![]() | Figure 2. Public Health framework for the possible linkages between HIV/AIDS and NCDs |
[1] | UNAIDS. UNAIDS report on the Global AIDS Epidemic 2010. Available at:http://www.unaids.org/globalreport/documents/20101123_GlobalReport_full_en.pdf. Accessed on June 6, 2012 |
[2] | US PEPFAR. PEPFAR Funding: Investments that save lives and promote security. Available at:http://www.pepfar.gov/documents/organization/80161.pdf. Accessed on June 6, 2012 |
[3] | World Health organization. Global Status report on Noncommunicable diseases 2010. Available at: http://www.who.int/nmh/publications/ncd_report_full_en.pdf. Accessed on June 6, 2012 |
[4] | United Nations General Assembly. Political declaration of the High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases. 66th session, Sept 2011. Paragraph 27 |
[5] | De Wit, S., et al., Incidence and risk factors for new-onset diabetes in HIV-infected patients. Diabetes Care, 2008. 31(6): p. 1224-1229. |
[6] | Brown, T.T., et al., Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Archives of Internal Medicine, 2005. 165(10): p. 1179-1184. |
[7] | Ledergerber, B., et al., Factors associated with the incidence of type 2 diabetes mellitus in HIV-infected participants in the Swiss HIV cohort study. Clinical Infectious Diseases, 2007. 45(1): p. 111-119. |
[8] | Tien, P.C., et al., Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study. AIDS, 2007. 21(13): p. 1739-1745 |
[9] | Banzi, R., et al., Conceptual frameworks and empirical approaches used to assess the impact of health research: An overview of reviews. Health Research Policy and Systems, 2011. 9. |
[10] | Coen, S.E., et al., A relational conceptual framework for multidisciplinary health research centre infrastructure. Health Research Policy and Systems, 2010. 8. |
[11] | Kagan, J.M., et al., Developing a conceptual framework for an evaluation system for the NIAID HIV/AIDS clinical trials networks. Health Research Policy and Systems, 2009. 7. |
[12] | Hommes, M.J.T., et al., Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected men. Metabolism: Clinical and Experimental, 1991. 40(6): p. 651-656. |
[13] | Grulich, A.E., et al., Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet, 2007. 370(9581): p. 59-67. |
[14] | Mujawar, Z., et al., Human immunodeficiency virus impairs reverse cholesterol transport from macrophages. PLoS biology, 2006. 4(11): p. e365. |
[15] | Butt, A.A., et al., HIV infection and the risk of diabetes mellitus. AIDS, 2009. 23(10): p. 1227-1234. |
[16] | Dube, M.P., Disorders of glucose metabolism in patients infected with human immunodeficiency virus. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 2000. 31(6): p. 1467-1475. |
[17] | Koeppe, J. and L. Kosmiski, Apparent resolution of type 2 diabetes mellitus after initiation of potent antiretroviral therapy in a man from Africa with HIV infection. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 2006. 42(10): p. e79-81. |
[18] | Mikhail, N., Insulin resistance in HIV-related lipodystrophy. Current Hypertension Reports, 2003. 5(2): p. 117-121. |
[19] | Crothers, K., Chronic Obstructive Pulmonary Disease in Patients Who Have HIV Infection. Clinics in Chest Medicine, 2007. 28(3): p. 575-587. |
[20] | Diaz, P.T., et al., Increased susceptibility to pulmonary emphysema among HIV-seropositive smokers. Annals of Internal Medicine, 2000. 132(5): p. 369-372. |
[21] | Crothers, K., et al., Increased COPD among HIV-positive compared to HIV-negative veterans. Chest, 2006. 130(5): p. 1326-1333. |
[22] | Magnusson, R.S., Non-communicable diseases and global health governance: Enhancing global processes to improve health development. Globalization and Health, 2007. 3. |
[23] | Coovadia, H.M. and J. Hadingham, HIV/AIDS: Global trends, global funds and delivery bottlenecks. Globalization and Health, 2005. 1. |
[24] | Schmid, G.P., et al., The unexplored story of HIV and ageing. Bulletin of the World Health Organization, 2009. 87(3): p. 162-162A. |
[25] | Hadigan, C., Dietary habits and their association with metabolic abnormalities in human immunodeficiency virus-related lipodystrophy. Clinical Infectious Diseases, 2003. 37(SUPPL. 2): p. S101-S104. |
[26] | Bopp, C.M., et al., Clinical implications of therapeutic exercise in HIV/AIDS. The Journal of the Association of Nurses in AIDS Care : JANAC, 2003. 14(1): p. 73-78. |
[27] | Jones, S.P., et al., Short-term exercise training improves body composition and hyperlipidaemia in HIV-positive individuals with lipodystrophy. AIDS, 2001. 15(15): p. 2049-2051. |
[28] | Ahoua, L., et al., Nutrition outcomes of HIV-infected malnourished adults treated with ready-to-use therapeutic food in sub-Saharan Africa: a longitudinal study. Journal of the International AIDS Society, 2011. 14: p. 2. |
[29] | Gorbach, S.L., T.A. Knox, and R. Roubenoff, Interactions between nutrition and infection with human immunodeficiency virus. Nutrition Reviews, 1993. 51(8): p. 226-234. |
[30] | Scrimshaw, N.S. and J.P. SanGiovanni, Synergism of nutrition, infection, and immunity: An overview. American Journal of Clinical Nutrition, 1997. 66(2): p. 464S-477S. |
[31] | Beisel, W.R., Nutrition and immune function: Overview. Journal of Nutrition, 1996. 126(10 SUPPL.): p. 2611S-2615S. |
[32] | Grinspoon, S. and A. Carr, Cardiovascular risk and body-fat abnormalities in HIV-infected adults. New England Journal of Medicine, 2005. 352(1): p. 48-62. |
[33] | Carr, A. and D. Ory, Does HIV cause cardiovascular disease? PLoS Medicine, 2006. 3(11): p. 1986-1987. |
[34] | Das, S., Insulin resistance and diabetes in HIV infection. Recent Patents on Anti-Infective Drug Discovery, 2011. 6(3): p. 260-268. |
[35] | Takarabe, D., et al., Autoimmune diabetes in HIV-infected patients on highly active antiretroviral therapy. Journal of Clinical Endocrinology and Metabolism, 2010. 95(8): p. 4056-4060. |
[36] | Engels, E.A., et al., Cancer risk in people infected with human immunodeficiency virus in the United States. International Journal of Cancer, 2008. 123(1): p. 187-194. |
[37] | Engels, E.A., et al., Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS, 2006. 20(12): p. 1645-1654. |
[38] | Silverberg, M.J. and D.I. Abrams, AIDS-defining and non-AIDS-defining malignancies: Cancer occurrence in the antiretroviral therapy era. Current Opinion in Oncology, 2007. 19(5): p. 446-451. |
[39] | Monini, P., et al., Antitumour effects of antiretroviral therapy. Nature Reviews Cancer, 2004. 4(11): p. 861-875. |
[40] | George, M.P., et al., Respiratory symptoms and airway obstruction in HIV-infected subjects in the HAART era. PLoS ONE, 2009. 4(7). |
[41] | Gingo, M.R., et al., Pulmonary function abnormalities in HIV-infected patients during the current antiretroviral therapy era. American Journal of Respiratory and Critical Care Medicine, 2010. 182(6): p. 790-796. |
[42] | Bader, M.S. and D.V. Kelly, Diagnosis and management of common chronic metabolic complications in HIV-infected patients. Postgraduate Medicine, 2008. 120(4): p. 17-27. |
[43] | Kim, P.S., et al., Increased prevalence of albuminuria in HIV-infected adults with diabetes. PLoS ONE, 2011. 6(9). |
[44] | Cheung, R.T.F., Neurological complications of heart disease. Bailliere's Clinical Neurology, 1997. 6(2): p. 337-355. |
[45] | Flower MJ. Micro vascular and Macro vascular Complications of Diabetes. Clinical Diabetes 2008; 26 (2): 77-82 |
[46] | Gale, N.S., et al., Does pulmonary rehabilitation address cardiovascular risk factors in patients with COPD? BMC Pulmonary Medicine, 2011. 11. |
[47] | Powles, T., et al., Hepatocellular cancer in HIV-infected individuals: Tomorrow's problem? Expert Review of Anticancer Therapy, 2006. 6(11): p. 1553-1558. |
[48] | Chaturvedi, A.K., et al., Risk of human papillomavirus-associated cancers among persons with AIDS. Journal of the National Cancer Institute, 2009. 101(16): p. 1120-1130. |
[49] | Jain, M.K., et al., Hepatitis C is associated with type 2 diabetes mellitus in HIV-infected persons without traditional risk factors. HIV Medicine, 2007. 8(8): p. 491-497. |
[50] | Datiko, D.G., et al., The rate of TB-HIV co-infection depends on the prevalence of HIV infection in a community. BMC public health, 2008. 8. |
[51] | Jeon, C.Y. and M.B. Murray, Diabetes mellitus increases the risk of active tuberculosis: A systematic review of 13 observational studies. PLoS Medicine, 2008. 5(7): p. 1091-1101. |
[52] | Szep, Z., et al., Vitamin D deficiency is associated with type 2 diabetes mellitus in HIV infection. AIDS, 2011. 25(4): p. 525-529. |
[53] | Inghammar, M., et al., COPD and the risk of tuberculosis - a population-based cohort study. PLoS ONE, 2010. 5(4). |
[54] | Dooley, K.E. and R.E. Chaisson, Tuberculosis and diabetes mellitus: convergence of two epidemics. The Lancet Infectious Diseases, 2009. 9(12): p. 737-746. |
[55] | Wang, T.J., et al., Vitamin D deficiency and risk of cardiovascular disease. Circulation, 2008. 117(4): p. 503-511. |
[56] | UNAIDS. Chronic care of HIV and Noncommunicable diseases: How to leverage the HIV experience. UNAIDS report 2010. |